Meriofert® 75IU Vial

Meriofert is a fertility medication containing menotropins, a combination of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) derived from the urine of postmenopausal women. It is used to stimulate ovarian follicle development in women undergoing assisted reproductive technologies (ART) such as in vitro fertilization (IVF). The balanced FSH and LH components in Meriofert promote follicular growth and maturation, supporting the ovulation process and improving the likelihood of successful egg retrieval. Administration:Meriofert 75 IU is typically administered via subcutaneous or intramuscular injection, daily during the ovarian stimulation phase. Dosage and duration depend on individual patient response and the fertility specialist’s protocol.